Business Wire

Takeda Receives Prestigious EURORDIS 2021 Black Pearl Award for Patient Engagement

Share

Takeda Pharmaceutical Company Limited(TSE:4502/NYSE:TAK) (“Takeda”) Takeda has been announced the winner of the EURORDIS 2021 Award for Patient Engagement in recognition of the company’s unwavering commitment to rare disease patients and its comprehensive partnerships with the rare disease patient community.

The annual EURORDIS Black Pearl awards ceremony is a celebration of achievements and exceptional work in this space and is held every February marking Rare Disease Day. Giles Platford, President Europe and Canada, will receive the award on behalf of Takeda during the virtual awards ceremony on 24 February 2021.

Commenting on the achievement, Mr. Platford said "Takeda is an organisation that truly embraces and demonstrates patient centricity. This award is an acknowledgement of the company’s breadth of initiatives and partnerships across the globe, that aim to create a brighter future for patients with rare diseases and their families. It is always humbling and inspiring to work alongside the people living with rare diseases, their caregivers and advocates to jointly find and develop solutions to the challenges they face every day."

During its 80+ year legacy in rare diseases, Takeda has consistently demonstrated commitment to improving the landscape of diagnosis, care and treatment for rare disease patients. As such, Takeda’s scope of patient engagement strives to cover the entire rare disease patient journey, from diagnosis through to patient access to therapy and innovative treatment support programs.

Commenting on the award, Yann Le Cam, Chief Executive Officer of EURORDIS-Rare Diseases Europe, said "This award acknowledges Takeda's readiness to stimulate patient-focused collaboration and improve the lives of people living with a rare disease through pioneering, multi-stakeholder initiatives. Takeda's engagement with the patient community actively contributes to raising rare disease awareness. Its support of key events and programmes - over time and around the world - helps elevate the voice of rare disease patients across diseases and borders."

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.

For more information, visit https://www.takeda.com.

Important Notice

For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.

The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.

Forward-Looking Statements

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations; the success of or failure of product development programs; decisions of regulatory authorities and the timing thereof; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/ reports/sec-filings/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

Contact information

Media Contacts:
Media Outside Japan
Luana Banu
luana.banu@takeda.com
+ 41 79 674 7224

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

L&T Technology Services Selected by Airbus for Skywise Partner Programme25.2.2021 08:04:00 CETPress release

L&T Technology Services (NSE: LTTS), a leading global pure-play engineering services company, announced that it has been selected by Airbus to provide technology and digital engineering solutions for Airbus’ Skywise platform as part of the ‘Skywise Partner Programme’. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224006261/en/ Abhishek Sinha, Chief Operating Officer and Board Member LTTS with Rémi Maillard, President & Managing Director, Airbus India & South Asia, commemorate LTTS joining the Skywise Partner Program (Photo: Business Wire) With more than 130 airlines around the world already connected to Skywise, the platform is playing a very important part in enabling and accelerating digital transformation of the aviation sector as a whole. LTTS will support the airlines in the development of complex workflows, creation of new interfaces between their existing information systems and Skywise and also provide assistance

Ecoppia Strengthens Its Presence in the Middle East with a first Project in Egypt25.2.2021 08:00:00 CETPress release

Ecoppia (TASE:ECPA), the pioneer and world leader in robotic solutions for photovoltaic solar, announced today a new project in one of the worlds’ largest solar parks in BenBan, Egypt. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224005973/en/ Ecoppia's light-weighted T4 solution, designed especially for Single Axis trackers. Completely autonomous, water-free, and energy independent. (Photo: Business Wire) BenBan solar park, located near the southern Egyptian city of Aswan, has a total capacity of 1,650 MWp corresponding to an annual production of approximately 3.8 TW, and is spread across nearly 40 km. While enjoying very high radiation rates, the facility also suffers from major soiling and desert sands, requiring frequent cleaning to ensure steady and optimal production. Ecoppia’s robotic solutions were proven to be extremely effective, cleaning nearly 10 million solar panels every night in harsh climatic conditions,

SES S.A.: Full Year 2020 Results25.2.2021 07:30:00 CETPress release

SES S.A. announces financial results for the year ended 31 December 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224006241/en/ SES S.A.: Full Year 2020 Results Third successive year delivering EBITDA outlook despite challenging COVID-19 environment in 2020 Growth engine Networks revenue +5% YOY(1,2), or +27% since 2017, and Video revenue of €1,108 million in line with expectations Adjusted EBITDA(3) of €1,152 million delivered within pre-COVID-19 financial outlook and at high end of mid-year outlook Strong net cash generated from operations of €1,049 million representing 97% of reported EBITDA Commitment to disciplined financial policy and shareholder returns Solid cash flow generation driving €505 million YOY debt reduction and lowest leverage ratio(4) (of 2.97 times) over the past 5 years Proposed 2020 dividend of €0.40 per A-share consistent with commitment to maintain a minimum base dividend of €0.40 On track

SES Extends Long-Term Partnership With Sky25.2.2021 07:00:00 CETPress release

Sky UK has extended its contract with SES for satellite capacity in a new agreement that will add over EUR 90 million in secured backlog. This renewal is in addition to capacity already under contract that extends through 2027. By the end of the renewed contract, Sky UK will have been an SES customer continuously for almost four decades, illustrating the strength and value of the partnership to Sky UK’s business in terms of the reliability, performance, high-quality viewing experience and the reach of SES’s satellite services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224006139/en/ SES Extends Long-Term Partnership With Sky (Photo: Business Wire) As part of the contract, SES will deliver Sky UK’s channels in a mix of standard definition (SD), high definition (HD) and ultra-high definition (UHD) from the 28.2/28.5 degrees East orbital slots to the operator’s subscribers across the United Kingdom and Republic of Irelan

ADVA announces record Q4 2020 results and reports full year 2020 figures25.2.2021 07:00:00 CETPress release

ADVA (ISIN: DE0005103006), a leading provider of open networking solutions for the delivery of cloud and mobile services, reported financial results for Q4 2020 and full year 2020 ended on December 31, 2020. The results have been prepared in accordance with International Financial Reporting Standards (IFRS). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224005994/en/ Brian Protiva, CEO, ADVA (Photo: Business Wire) Q4 2020 financial summary1 (in thousands of EUR) Q4 Q4 Change Q3 Change 2020 2019 2020 Revenues 140,572 151,135 -7.0% 146,676 -4.2% Pro forma gross profit 54,641 54,633 0.0% 51,930 5.2% in % of revenues 38.9% 36.1% 2.8pp 35.4% 3.5pp Pro forma operating income 14,343 10,333 38.8% 11,053 29.8% in % of revenues 10.2% 6.8% 3.4pp 7.5% 2.7pp Operating income (loss) 13,085 5,438 140.6% 9,768 34.0% Net income 13,249 2,522 425.3% 6,671 98.6% (in thousands of EUR) Dec. 31 Dec. 31 Change Sep. 30 Change 2020 2019 2020 Cash

Protembis Announces Completion of 20 Cases in European CE Mark Study With the ProtEmbo ® Cerebral Protection System25.2.2021 06:15:00 CETPress release

Protembis GmbH, a privately held emerging medical device company, announced today the successful completion of 20 clinical cases in its European regulatory study of the ProtEmbo® Cerebral Protection System. The ProtEmbo® System is an intra-aortic filter device that deflects embolic material away from the brain during transcatheter aortic valve replacement (TAVR). The device is a low profile system which is delivered through the left radial artery, an ideal access site enabling physicians to avoid interference with TAVR equipment, typically delivered through the left femoral artery. Nikos Werner, M.D., Professor of Medicine, Head of Cardiology at the Heart Center Trier, Germany, and Principal Investigator in Germany commented: “Embolic protection in TAVR procedures has been shown to be effective in reducing the ischemic burden in the brain, but physicians look forward to next generation devices that are easy to use, cover all three potential access arteries to the brain, and can be simp

Wipro Marks 25 Years of Partnership With Cisco; Launches Cisco Business Unit25.2.2021 06:00:00 CETPress release

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting, and business process services company, is celebrating the 25th anniversary of its business partnership with Cisco (NASDAQ: CSCO), the worldwide leader in technology that powers the Internet. To commemorate this milestone, Wipro is launching the Cisco Business Unit that will focus on the development and adoption of end-to-end digital transformation solutions leveraging Cisco technologies for customers. This strategic initiative demonstrates Wipro’s commitment to its business relationship with Cisco. Also, it is a growth accelerator for the successful and well-established 360-degree partnership of several years. Over the course of 25 years, Wipro has focused on delivering its transformative service capabilities across Digital, Cloud, Security, and Engineering, which are aligned with Cisco’s operational priorities. Wipro and Cisco co-develop communications, infrastructure, and security

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom